Curevo Vaccine Alternatives & Competitors
12 companies similar to Curevo Vaccine — A clinical-stage biotech company developing amezosvatein, a vaccine for shingles...
Companies similar to Curevo Vaccine
EMERGEX VACCINES LTD
A UK biotechnology company developing T cell-priming immune set-point candidates against i...
United Kingdom
Osivax
Pioneering A New Class of Universal Vaccines
Lyon, France
AVM Biotechnology
#Clinical-Stage Biotech Company #2024-NIH Innovation Company #Showcase Company (2023-NCI;...
Seattle, United States
VBI Vaccines Inc.
Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease
Cambridge, United States
Rival Readout
Competing with Curevo Vaccine? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Valneva
Specialty vaccine company focused on prevention of infectious diseases with major unmet ne...
Saint-herblain, France
-logo.jpg "VBL Therapeutics (Nasdaq:VBLT)"){kind=logo}
VBL Therapeutics (Nasdaq:VBLT)
Engineering the future of targeted medicines, breaking barriers to develop the next genera...
Israel
NEC OncoImmunity AS
Empowering cancer immunotherapy with artificial intelligence
Oslo, Norway
BioVaxys Technology Corp.
Antiviral and Anticancer Vaccine Platforms Harnessing the Power of T-Cells
Etobicoke, Canada
Drug Discovery & Development
Strategies and technologies driving drug discovery to market.
Cleveland, United States
FLUGEN, INC.
Transforming vaccine efficacy in respiratory disease.
About Curevo Vaccine
Curevo Vaccine, founded in 2017, is a clinical-stage biotech company based in the United States. Specializing in the development of vaccines for varicella and herpes zoster, the company is advancing its flagship product, Amezosvatein (CRV-101), a non-mRNA, adjuvanted subunit vaccine aimed at preventing shingles. The co...
Development of next-generation non-mRNA vaccines, Clinical trials for vaccine efficacy and safety, Comparative studies with existing vaccines, Improving tolerability and accessibility of vaccines
Individuals susceptible to shingles and chickenpox, Immunocompromised patients, particularly children, Healthcare providers and institutions, Global health organizations and vaccine distributors
Biotech, Vaccine Development, Clinical-Stage Biotech, Amezosvatein, Herpes Zoster Vaccine, Chickenpox Vaccine, Shingles Vaccine, Varicella Zoster Virus, Adjuvanted Subunit Vaccine, Immunology, Drug Development, Reactogenicity Improvement, Public Health, Infectious Disease, Clinical Trials
B2B, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Curevo Vaccine: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Curevo Vaccine on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
